Evidence map›Paper›PMID 22244687›Full record

ArticleClinical and experimental rheumatology

New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).

Brett D Thombs, Lisa R Jewett, Shervin Assassi, Murray Baron, Susan J Bartlett, Angela Costa Maia, Ghassan El-Baalbaki, Daniel E Furst, Karen Gottesman, Jennifer A Haythornthwaite and 25 more

Abstract read
In one paragraph

Article in Clinical and experimental rheumatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 14 institutions in 5 countries.

Brett D ThombsJewish General Hospital, Montreal, Quebec, Canada. brett.thombs@mcgill.ca
Lisa R Jewett
Shervin Assassi
Murray Baron
Susan J Bartlett
Angela Costa Maia
Ghassan El-Baalbaki
Daniel E Furst
Karen Gottesman
Jennifer A Haythornthwaite
Marie Hudson
Ann Impens
Annett Korner
Catarina Leite
Maureen D Mayes
Vanessa L Malcarne
Sarosh J Motivala
Luc Mouthon
Warren R Nielson
Diane Plante
Serge Poiraudeau
Janet L Poole
Janet Pope
Maureen Sauve
Russell J Steele
Maria E Suarez-Almazor
Suzanne Taillefer
Cornelia H van den Ende
Erin Arthurs
Marielle Bassel
Vanessa Delisle
Katherine Milette
Allison Leavens
Ilya Razykov
Dinesh Khanna
McGill University · CASan Diego State University · USScleroderma Foundation · USThe University of Texas Health Science Center at Houston · USUniversity of California, Los Angeles · USUniversity of Michigan · USGeneral Department of Preventive Medicine · VNInserm · FRJewish General Hospital · CAJohns Hopkins University · USMultiple Sclerosis Society of Canada · CAUniversité Paris Cité · FRUniversity of Minho · PTWestern University · CA

Funding

NIH PROMIS Statistical Coordinating Center(RMI)U01AR052177 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CELLA, DAVID · 2004 to 2010
$10.6M
Role of TGF-beta and CTGF Signaling Transgenic Mouse Models of SclerodermaP50AR054144 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CROMBRUGGHE, BENOIT DE · 2006 to 2010
$7.7M
Development and Initial Validation of PROMIS GI Distress ScaleU01AR057936 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KHANNA, DINESH, SPIEGEL, BRENNAN · 2009 to 2013
$2.2M
Health Values and Minimally Important Differences in Systemic SclerosisK23AR053858 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KHANNA, DINESH · 2007 to 2011
$617k
Aging: Insomnia Treatment and Energy BalanceK23AG027860 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MOTIVALA, SAROSH J · 2006 to 2010
$609k
CIHRNIAMS NIH HHS AR052177NIAMS NIH HHS K23 AR053858NIAMS NIH HHS K23 AR053858-04NIAMS NIH HHS P50 AR054144NIAMS NIH HHS P50-AR054144NIAMS NIH HHS U01 AR052177NIAMS NIH HHS U01 AR057936NIAMS NIH HHS U01 AR057936ANIA NIH HHS K23 AG027860
6 · The paper itself

Abstract

Systemic sclerosis (SSc), or scleroderma, is a chronic multisystem autoimmune disorder characterised by thickening and fibrosis of the skin and by the involvement of internal organs such as the lungs, kidneys, gastrointestinal tract, and heart. Because there is no cure, feasibly-implemented and easily accessible evidence-based interventions to improve health-related quality of life (HRQoL) are needed. Due to a lack of evidence, however, specific recommendations have not been made regarding non-pharmacological interventions (e.g. behavioural/psychological, educational, physical/occupational therapy) to improve HRQoL in SSc. The Scleroderma Patient-centred Intervention Network (SPIN) was recently organised to address this gap. SPIN is comprised of patient representatives, clinicians, and researchers from Canada, the USA, and Europe. The goal of SPIN, as described in this article, is to develop, test, and disseminate a set of accessible interventions designed to complement standard care in order to improve HRQoL outcomes in SSc.

Indexed as

Cooperative BehaviorInterdisciplinary CommunicationInternational CooperationQuality of LifeCanadaEuropeEvidence-Based MedicineHealth Services Needs and DemandHumansOrganizational ObjectivesPatient AdvocacyPatient-Centered CarePhysiciansProgram DevelopmentResearch PersonnelScleroderma, Systemic

Identifiers

PMID22244687
PMCPMC3925434
OpenAlexW2244485377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.